Futura Biolabs is a UK-based research peptide supplier established in 2025, following years of research into what the market was consistently failing to deliver: transparent quality, traceable purity, and a supplier researchers can actually trust.
Futura Biolabs was founded in 2025 by a group of UK-based researchers who had grown frustrated with the fragmented, opaque landscape of peptide sourcing. After years of working in research environments, we saw first-hand how difficult it was to source compounds that were genuinely verified — where the Certificate of Analysis reflected the actual batch, not a template.
We spent over twelve months prior to launch establishing rigorous testing protocols, vetting third-party analytical labs, and building a supply chain that puts quality at every checkpoint. When we opened our catalogue, every single product had undergone independent HPLC and mass spectrometry analysis. That standard hasn't changed.
Today, Futura Biolabs operates exclusively within the UK, dispatching via Royal Mail with full tracking. Every order ships discreetly. Every product page carries the real batch CoA. We are not a marketplace — every compound is sourced and tested by us before it ever reaches a customer.
Every batch is independently tested via HPLC and mass spectrometry. A genuine batch-specific Certificate of Analysis is published on every product page — not a generic document.
We are a UK-registered supplier operating under UK law. All stock is held domestically and dispatched via Royal Mail Tracked 24 or Tracked 48, with discreet, unmarked packaging on every order.
All compounds are supplied strictly for research and laboratory use. We do not provide dosing advice. Our responsibility is to supply the highest-quality material possible for legitimate scientific enquiry.
Founders spend twelve months mapping the UK research peptide market, identifying critical gaps in CoA transparency, supply traceability, and customer communication.
Launched as a UK-registered research peptide supplier. First catalogue published with independently-verified batch CoAs on every listed compound from day one.
Established partnerships with accredited UK analytical laboratories for ongoing independent HPLC and mass spectrometry verification of all compounds.
Expanding our range of research-grade peptides in response to researcher demand — each new addition held to the same purity and documentation standards as our originals.
Important Notice
All compounds sold by Futura Biolabs are supplied strictly for in vitro research and laboratory use only. They are not approved for, or intended for, any therapeutic, diagnostic, or clinical application. By purchasing from us you confirm that you are a qualified researcher operating within applicable UK legal frameworks.